Evidence map›Paper›PMID 40978789›Full record

ArticleFrontiers in plant science2025

TriPerceptNet: a lightweight multi-scale enhanced YOLOv11 model for accurate rice disease detection in complex field environments.

Xin Zhang, Linjing Wei, Ruqiang Yang

Abstract read
In one paragraph

Article in Frontiers in plant science, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Xin ZhangCollege of Information Science and Technology, Gansu Agricultural University, Lanzhou, Gansu, China.
Linjing WeiCollege of Information Science and Technology, Gansu Agricultural University, Lanzhou, Gansu, China.
Ruqiang YangCollege of Information Science and Technology, Gansu Agricultural University, Lanzhou, Gansu, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This study proposes EDGE-MSE-YOLOv11, a novel lightweight rice disease detection model based on a unified Tri-Module Lightweight Perception Mechanism (TMLPM). This mechanism integrates three core components: multi-scale feature fusion (C3K2 MSEIE), attention-guided feature refinement (SimAM), and efficient spatial downsampling (ADown), which significantly enhance the model's ability to detect multi-scale and small disease targets under complex field conditions. Unlike isolated architectural enhancements, TMLPM supports collaborative feature interactions, which significantly improves the interpretability and computational efficiency of the model under complex environmental conditions. Experimental results show that, compared with the baseline YOLOv11n model, EDGE-MSE-YOLOv11 improves precision (from 85.6% to 89.2%), recall (from 82.6% to 86.4%), mAP@0.5 (from 90.2% to 92.6%), and mAP@0.5:0.95 (from 63.7% to 70.3%). The model also reduces parameter count by 0.69M and computational cost by 0.3 GFLOPs, while maintaining a high inference speed of 111.6 FPS. These results validate its effectiveness in identifying small, dense lesion areas with high accuracy and efficiency. However, the model still faces challenges in detecting ultra-small or occluded lesions under extremely complex conditions and has yet to be evaluated across multiple domains. Future work will focus on cross-domain generalization and deployment optimization using lightweight techniques such as quantization, pruning, and transformer-based enhancements, aiming to build a robust and scalable disease diagnosis system for intelligent agriculture.

Indexed as

ADownC3K2 MSEIEGradCAM++lightweight CNNrice disease detectionSimAMTMLPMYOLOv11

Identifiers

PMID40978789
PMCPMC12445169

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.